Corticosteroid therapy in a case of severe cholestasic hepatitis associated with amoxicillin-clavulanate.

PubWeight™: 0.85‹?›

🔗 View Article (PMC 3550477)

Published in J Med Toxicol on December 01, 2010

Authors

José-Ignacio Herrero-Herrero1, Judit García-Aparicio

Author Affiliations

1: Service of Internal Medicine-Los Montalvos, Universitary Hospital of Salamanca, Salamanca, Spain.

Articles cited by this

Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol (1993) 7.63

Drug-induced hepatotoxicity. N Engl J Med (2003) 7.11

Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology (2005) 3.52

Acute and clinically relevant drug-induced liver injury: a population based case-control study. Br J Clin Pharmacol (2004) 1.95

Co-amoxiclav jaundice: clinical and histological features and HLA class II association. Gut (2000) 1.78

Practical guidelines for diagnosis and early management of drug-induced liver injury. World J Gastroenterol (2008) 1.69

Determinants of the clinical expression of amoxicillin-clavulanate hepatotoxicity: a prospective series from Spain. Hepatology (2006) 1.32

Hepatitis associated with amoxycillin-clavulanic acid combination report of 15 cases. Gut (1992) 1.28

Steroid therapy for a case of severe drug-induced cholestasis. Ann Pharmacother (2006) 1.01

[Cholestatic hepatitis caused by a combination of amoxicillin and clavulanic acid (Augmentin)]. Ned Tijdschr Geneeskd (1988) 0.94

Antibiotic therapy: a major cause of drug-induced jaundice in southwest England. Eur J Gastroenterol Hepatol (2007) 0.89

[Hepatic failure secondary to hepatitis due to amoxicillin-clavulanic acid. Treatment with corticoids]. An Med Interna (2002) 0.88

Diagnosis and treatment of autoimmune hepatitis. Gastroenterol Clin North Am (2008) 0.86

Amoxicillin-clavulanic acid therapy may be associated with severe side effects -- review of the literature. Eur J Med Res (2001) 0.84

Risk factors for the development of amoxycillin-clavulanic acid associated jaundice. Med J Aust (1995) 0.82

Ursodeoxycholic acid (UDCA) for the treatment of amoxycillin-clavulanate potassium (Augmentin)-induced intra-hepatic cholestasis: report of two cases. Eur J Gastroenterol Hepatol (2000) 0.81